0.9% Sodium Chloride Injection, USP BD PosiFlush SF Saline Flush Syringe
K-Number: K231161 · 2023-07-21
Device Summary
Frequently Asked Questions
What is the 0.9% Sodium Chloride Injection, USP BD PosiFlush SF Saline Flush Syringe?
0.9% Sodium Chloride Injection, USP BD PosiFlush SF Saline Flush Syringe is a medical device that received FDA 510(k) clearance on 2023-07-21. It is manufactured by Becton, Dickinson and Company. The 510(k) number is K231161.
When was 0.9% Sodium Chloride Injection, USP BD PosiFlush SF Saline Flush Syringe approved by the FDA?
0.9% Sodium Chloride Injection, USP BD PosiFlush SF Saline Flush Syringe received FDA 510(k) clearance on 2023-07-21, under approval number K231161.
What company makes 0.9% Sodium Chloride Injection, USP BD PosiFlush SF Saline Flush Syringe?
0.9% Sodium Chloride Injection, USP BD PosiFlush SF Saline Flush Syringe is manufactured by Becton, Dickinson and Company.
What is the FDA product code for 0.9% Sodium Chloride Injection, USP BD PosiFlush SF Saline Flush Syringe?
The FDA product code for 0.9% Sodium Chloride Injection, USP BD PosiFlush SF Saline Flush Syringe is NGT.
Related Clinical Trials
Other Devices by Becton, Dickinson and Company
Related Devices (Code: NGT)
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.